SIRT1 and neoplasm: Interestingly, in contrast to the tumor-promoting effect of MSCs described previously, MSCs that over-express Sirtuin 1 (MSC-Sirt1) can inhibit prostate cancer tumor growth by inducing IFN-γ production in vivo.